Arch Therapeutics to Present at The Biotech Showcase(TM) 2015 Conference on January 14th 2015

WELLESLEY, MA (Marketwired Dec 17, 2014) Arch Therapeutics, Inc. (OTCQB: ARTH) ( Arch or the Company ), developer of the AC5 Surgical Hemostatic Device™, announced that it would be featured as a presenting company at The Biotech Showcase™ 2015 Conference on Wednesday, January 14, 2015 at 11:00 AM PST. The conference will be held at the Parc 55 Wyndham Hotel, located at Union Square, San Francisco, California. Chief Executive Officer Terrence W. Norchi, MD, will provide a corporate update, including a discussion of recent differentiating data and plans for calendar year 2015. Biotech Showcase is among the premier events taking place during what many healthcare companies, investors, and business development executives believe to be one of the most productive and important weeks of the year. About Arch Therapeutics, Inc. (OTCQB: ARTH) Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during s
http://bit.ly/1zvQgPf